Rosanne Fohn, Author at UT Health Science Center News

UT Health researchers developing new drug to fight therapy-resistant ER-positive breast cancer 0
- News Releases
- August 9, 2017
SAN ANTONIO (Aug. 9, 2017) ― Researchers at UT Health San Antonio and two partner institutions are developing a new, first-in-class agent that has stopped the growth of estrogen receptor-positive breast cancer in its tracks. The new agent is a molecule called ERX-11 that has blocked the growth of recurring breast cancer tumors. Ratna Vadlamudi, Ph.D.,
READ MORE
Researcher contributes to screening guidelines for pediatric cancers 0
- My UT Health, Research, School of Medicine, Uncategorized
- August 2, 2017
Panel will determine guidelines for more than 50 of the most common syndromes that can develop into pediatric cancer.
READ MORE

UT Health San Antonio physician-researcher contributes to international screening guidelines for rare pediatric cancers 0
- News Releases
- August 2, 2017
SAN ANTONIO (Aug. 2, 2017) ―Approximately 10 percent of childhood cancer can be attributed to genetics. While genomic analysis has been used for some time to identify the risk of inherited cancer in adults, scientists are now using genomic analysis to identify genetic risk factors and to diagnose cancer at an early age in children.
READ MORE
Zebrafish model explains how recurring cancer may resist treatment 0
- Research, School of Medicine, Uncategorized
- July 21, 2017
UT Health San Antonio researchers are learning how stem cell biology causes 30 percent of children who have a rare muscle cancer to relapse and not respond to treatment.
READ MORE